Author/Creator: Peeva, E. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Peeva, E.

1. 56 PROLACTIN ALTERS BCR-MEDIATED APOPTOSIS AND RECEPTOR EDITING. (1st March 2007)

Authors:: Peeva, E.; Rosenfeld, G. E.; Gonzalez, J.; Saha, S.
Journal:: Journal of investigative medicine
Issue:: Volume 55:Number 2(2007)
Page Start:: S357
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0572 Meta-analysis of the key rheumatoid arthritis (RA) disease activity endpoints in patients treated with B-cell depleting therapies. (23rd January 2014)

Authors:: Menon, S.; Barker, K.; Peeva, E.; Gourley, I.; Heatherington, A.
Journal:: Annals of the rheumatic diseases
Issue:: Volume 71(2012)Supplement 3
Page Start:: 671
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterizing the relationships between patient‐reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib. (25th January 2022)

Authors:: Winnette, R.; Banerjee, A.; Sikirica, V.; Peeva, E.; Wyrwich, K.
Journal:: Journal of the European Academy of Dermatology and Venereology
Issue:: Volume 36:Number 4(2022)
Page Start:: 602
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study. (1st July 2018)

Authors:: Schmieder, G.J.; Draelos, Z.D.; Pariser, D.M.; Banfield, C.; Cox, L.; Hodge, M.; Kieras, E.; Parsons‐Rich, D.; Menon, S.; Salganik, M.; Page, K.; Peeva, E.
Journal:: British journal of dermatology
Issue:: Volume 179:Number 1(2018)
Page Start:: 54
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study. (6th March 2018)

Authors:: Schmieder, G.J.; Draelos, Z.D.; Pariser, D.M.; Banfield, C.; Cox, L.; Hodge, M.; Kieras, E.; Parsons‐Rich, D.; Menon, S.; Salganik, M.; Page, K.; Peeva, E.
Journal:: British journal of dermatology
Issue:: Volume 179:Number 1(2018)
Page Start:: 54
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Monoclonal antibody against macrophage colony‐stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus. (9th November 2015)

Authors:: Masek‐Hammerman, K.; Peeva, E.; Ahmad, A.; Menon, S.; Afsharvand, M.; Peng Qu, R.; Cheng, J. B.; Syed, J.; Zhan, Y.; O'Neil, S. P.; Pleasic‐Williams, S.; Cox, L.A.; Beidler, D.
Journal:: Clinical and experimental immunology
Issue:: Volume 183:Number 2(2016:Feb.)
Page Start:: 258
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice. (10th April 2013)

Authors:: Gonzalez, J.; Saha, S.; Peeva, E.
Journal:: Clinical and experimental immunology
Issue:: Volume 172:Number 2(2013:May)
Page Start:: 311
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗